Biotech company , Vgenomics raises seed investment from Mumbai Angels & others
Human Biologicals Institute ( HBI ), a division of Indian Immunologicals Limited ( IIL ) launched the Mabella ( Measles and Rubella ) vaccine for children . This live attenuated MR vaccine has been developed by IIL in an exclusive partnership with Polyvac Institute , Vietnam . Through extensive human clinical trials , Mabella has been proven to be safe and effective . Upon request from Government of India , HBI indigenously developed India ’ s 1st safe Vero-cell rabies vaccine – Abhayrab in 1998 , paving way for Government of India to phase out the painful nerve tissue vaccine .
Biological E ’ s CORBEVAX vaccine receives EUL authorization from WHO
Biological E . Limited ( BE ) has announced that the World Health Organization ( WHO ) has granted an Emergency Use Listing ( EUL ) to their CORBEVAX vaccine , which is India ’ s first indigenously developed COVID- 19 vaccine that is based on protein sub-unit platform . The Drugs Controller General of India ( DCGI ) already approved CORBEVAX for restricted use in emergency among adults , adolescents and young children in a sequential manner from December ’ 21 to April ’ 22 ; as well as India ’ s first heterologous COVID-19 booster shot for adults age 18 and above in June ’ 22 .
BE supplied 100 million doses of
CORBEVAX to the Government of India which were then utilized in pan- India immunization campaigns : mainly in 12 – 14-year-old children . The CORBEVAX vaccine is administered through intramuscular route with two doses scheduled 28 days apart and is stored at 2 to 8 degrees Celsius temperature and presented as 0.5 ml ( single dose ) vial , 5 ml ( 10 doses ) vial and 10 mL ( 20 doses ) vial pack .
BioTech
BIOVOICENEWS . COM 11